Fluconazole Tablet
Product Images NDC 57237-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluconazole (NDC 57237-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Directions: Push Tablet Through Foil And Take By Mouth (Fluconazole Fig1)

FDA Label Image

Package Label-principal Display Panel (50 mg (30 Tablet Bottle))

Package Label-principal Display Panel (50 mg (30 Tablet Bottle))
This text describes a medication called Rising® NDC, which comes in tablet form and contains fluconazole. It provides instructions to store the tablets at a temperature range and includes a unique code for distribution. There is also information about the manufacturer and revision date.*
FDA Label Image

Package Label-principal Display Panel (100 mg (30 Tablet Bottle))

Package Label-principal Display Panel (100 mg (30 Tablet Bottle))
Rising® NDC 57237-004-30 Exh table contains 100mg of fluconazole &tesizpmez. It is distributed by TSDRUGS and should be stored at 20°C to 25°C. The package contains 30 tablets and was revised in December 2017. The print quality over the coding area is not readable.*
FDA Label Image

Package Label-principal Display Panel (150 mg Blister Carton (12 Cards x 1 Tablet))

Package Label-principal Display Panel (150 mg Blister Carton (12 Cards x 1 Tablet))
Fluconazole Tablet USP is an easy oral cure for most vaginal yeast infections, due to Candida. It is a unique treatment as it is taken orally and just one oral tablet provides a full course of therapy sufficient to cure most vaginal yeast infections. The tablet can be taken anytime – day or night, with or without meals, to ensure relief and the earliest possible relief from the infection and its symptoms. Relief of symptoms can be expected within 24 hours of taking the tablet, although it may take several days for a complete cure. Contact your doctor if your symptoms have not improved within three to five days. The most common side effects of fluconazole are headache, nausea, and abdominal pain, which are mild to moderate in nature. Do not take fluconazole if you are taking Propuisid® (cisapride) medication. The usual dosage is one 150 mg tablet, and the tablet should be pushed through the foil and taken by mouth.*
FDA Label Image

Package Label-principal Display Panel (200 mg (30 Tablet Bottle))

Package Label-principal Display Panel (200 mg (30 Tablet Bottle))
This is a description of a medication called "Fluconazole Tablet USP" which is used to cure most vaginal yeast infections caused by Candida. It comes in a pack of 12 cards, each containing a single tablet of 150 mg. The usual dosage is mentioned along with instructions for storing the medication at controlled temperatures. The medication is distributed by a company called Rising Health LLC based in Saddle Brook, NJ. It was made in India and has a TS/DRUGS 19/1983 code along with a revision date of 0812022.*
FDA Label Image

Package Label-principal Display Panel (150 mg Catch Cover (1 Card x 1 Tablet))

Package Label-principal Display Panel (150 mg Catch Cover (1 Card x 1 Tablet))
Rising® NDC 57237-006-30 is a container of tablets containing 200mg of Fluconazole. The container follows the USP description and contains 30 tablets. It is distributed by TSDrugs and was revised in 12/2017. Storage is recommended in the range of 20-25°C (68-77°F) with excursions permitted up to 16-30°C (59-86°F). There is an over printing zone and coding area specified as 45 x 15 mm.*
FDA Label Image

Chemical Structure (Fluconazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.